Editorial: Sex hormones and cardiovascular-renal health: mechanisms, consequences, and therapeutic insights - Report - MDSpire

Editorial: The Role of Sex Hormones in Cardiovascular and Renal Health: Mechanisms, Implications, and Treatment Perspectives

  • By

  • Prerna Kumar

  • Evangeline Deer

  • Noha Shawky Elsayed

  • July 21, 2026

Share

Clinical Report: The Role of Sex Hormones in Cardiovascular and Renal Health

Overview

This editorial discusses the influence of sex hormones on cardiovascular and renal health, highlighting the increased cardiovascular risk in women during the menopausal transition.

Background

Sex hormones play a critical role in regulating various physiological processes that impact cardiovascular and renal health. Understanding these mechanisms is essential for addressing sex-based differences in disease risk and outcomes. The editorial emphasizes the need for more focused studies on hormonal changes during menopause and their correlation with cardiovascular disease risk in women.

Data Highlights

No specific numerical data provided in the source material.

Key Findings

  • Sex steroids regulate endothelial function, vascular tone, and inflammatory signaling.
  • Women are at lower risk of cardiovascular disease during reproductive years, but this changes post-menopause.
  • Postmenopausal women exhibit higher body mass index and blood pressure compared to perimenopausal women.
  • Estimated glucose disposal rate (eGDR) is associated with cardiovascular disease risk.
  • Corin levels may serve as a potential biomarker for left atrial reverse remodeling in atrial fibrillation patients.

Clinical Implications

Clinicians should consider the hormonal status of women during the menopausal transition when assessing cardiovascular risk.

Conclusion

The editorial highlights the need for further research into the role of sex hormones in cardiovascular and renal health, particularly in women during menopause.

Related Resources & Content

  1. Frontiers in Endocrinology, 2023 -- Cardiovascular risks in cardiovascular-kidney-metabolic syndrome: mechanisms and therapies
  2. European Journal of Preventive Cardiology, 2023 -- The Importance of Cardiovascular Disease Publications in Addressing Sex and Gender in Research
  3. Frontiers in Cardiovascular Medicine, 2023 -- New frontiers in heart failure therapy: mechanisms, efficacy, and challenges
  4. Hub - Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention, American Heart Association
  5. The Women’s Health Initiative Randomized Trials and Clinical Practice: A Review, JAMA Network
  6. Frontiers in Cardiovascular Medicine — Editorial: HDL and cardiovascular disease: mechanisms, clinical relevance, and therapeutic impacts
  7. Hub - Menopause Transition and Cardiovascular Disease Risk: Implications for Timing of Early Prevention - Professional Heart Daily | American Heart Association
  8. The Women’s Health Initiative Randomized Trials and Clinical Practice: A Review | Oncology | JAMA | JAMA Network
  9. Cardiovascular Safety of Testosterone-Replacement Therapy | New England Journal of Medicine
  10. CKD Evaluation and Management – KDIGO
  11. Women and kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference

Original Source(s)

Related Content